Supplemental material
Emerging Microbes & Infections
Volume 11, 2022 - Issue 1
Open access
3,214
Views
6
CrossRef citations to date
0
Altmetric
Antimicrobial Agents
N-chlorotaurine is highly active against respiratory viruses including SARS-CoV-2 (COVID-19) in vitro
Michaela Lacknera Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austriahttps://orcid.org/0000-0001-9073-2886View further author information
, Annika Rösslerb Institute of Virology, Medical University of Innsbruck, Innsbruck, Austriahttps://orcid.org/0000-0002-5298-0288View further author information
, André Vollandb Institute of Virology, Medical University of Innsbruck, Innsbruck, Austriahttps://orcid.org/0000-0003-2805-8215View further author information
, Marlena Nastassja Stadtmüllerc Unit 17-Influenza and Other Respiratory Viruses, Robert Koch-Institute, Berlin, Germanyhttps://orcid.org/0000-0001-8893-5326View further author information
, Brigitte Müllauerb Institute of Virology, Medical University of Innsbruck, Innsbruck, AustriaView further author information
, Zoltan Bankib Institute of Virology, Medical University of Innsbruck, Innsbruck, Austriahttps://orcid.org/0000-0002-3826-5800View further author information
, Johannes Ströhlea Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, AustriaView further author information
, Angela Luttickd 360biolabs Pty Ltd, Melbourne, AustraliaView further author information
, Jennifer Fennerd 360biolabs Pty Ltd, Melbourne, AustraliaView further author information
, Bettina Sarge Institute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austriahttps://orcid.org/0000-0002-4785-8739View further author information
, Leopold Kremsere Institute of Medical Biochemistry, Biocenter, Medical University of Innsbruck, Innsbruck, AustriaView further author information
, Paul Tonef Innovative Biomedical Concepts, Inc., Staten Island, NY, USAView further author information
, Heribert Stoiberb Institute of Virology, Medical University of Innsbruck, Innsbruck, Austriahttps://orcid.org/0000-0002-4266-8397View further author information
, Dorothee von Laerb Institute of Virology, Medical University of Innsbruck, Innsbruck, Austriahttps://orcid.org/0000-0001-5825-7237View further author information
, Thorsten Wolffc Unit 17-Influenza and Other Respiratory Viruses, Robert Koch-Institute, Berlin, Germanyhttps://orcid.org/0000-0001-7688-236XView further author information
, Carsten Schwarzg CF Center Westbrandenburg, Division Cystic Fibrosis, Pediatric Clinic Westbrandenburg, Potsdam, Germanyhttps://orcid.org/0000-0002-1461-4439View further author information
& Markus Nagla Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, AustriaCorrespondence[email protected]
https://orcid.org/0000-0002-1225-9349View further author information
show allhttps://orcid.org/0000-0002-1225-9349View further author information
Pages 1293-1307
|
Received 30 Dec 2021, Accepted 10 Apr 2022, Published online: 23 May 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.